Sector pending / Medicinal Chemicals and Botanical ProductsUpdated 2026-05-10 22:07 UTC

BOM/524412 stock hub

BOM/524412 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BOM/524412is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6B

Bombay Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BOM/524412

In the news

Latest news · BOM/524412

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E77.1

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC0.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BOM/524412 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

INR

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	132
Enterprise value	INR 3.1B
Exchange	Bombay Stock Exchange
Financial currency	INR
First seen	2026-05-10
Industry	Medicinal Chemicals and Botanical Products
Last refreshed	2026-05-10
Market cap	INR 2.6B
Price	INR 87.75
Price currency	INR
Rev Per Employee	29,613,333.33x
Sic	2833
Symbol	bom/524412
Website	https://www.aareydrugs.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.31%
EV Earnings	90.41x
EV/EBITDA	124.09x
EV/Sales	0.79x
P/B ratio	1.76x
P/E ratio	77.07x
P/S ratio	0.67x
PE Ratio10 Y	23.31x
PE Ratio3 Y	36.57x
PE Ratio5 Y	28.72x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.1%
EBITDA Margin	0.64%
Gross margin	1.67%
Gross Profit	INR 65.5M
Gross Profit Growth	-72.93%
Gross Profit Growth3 Y	-25.84%
Gross Profit Growth5 Y	-10.19%
Net Income	INR 34.4M
Net Income Growth	-39.8%
Net Income Growth Q	-20.68%
Net Income Growth3 Y	8.92%
Net Income Growth5 Y	-10.86%
Pretax Margin	1.47%
Profit Margin	0.88%
Profit Per Employee	INR 260,227
Roa5y	1.94
Roe5y	4.59
ROIC	0.11
Roic5y	4.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.23%
Cagr15y	10.74%
Cagr1y	65.87%
Cagr3y	45.62%
Cagr5y	23.06%
EPS Growth	-42.64
EPS Growth Q	-21.85
EPS Growth3 Y	2.88
EPS Growth5 Y	-14.48
Revenue Growth	-32.97x
Revenue Growth Q	-27.93x
Revenue Growth3 Y	1.23x
Revenue Growth5 Y	6.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 81.9M
Debt	INR 569.6M
Debt EBITDA	INR 22.76
Debt Equity	INR 0.38
Equity	INR 1.5B
Interest Coverage	0.11
Net Cash	INR -487.7M
Net Cash By Market Cap	INR -18.63
Net Debt EBITDA	INR 19.49
Net Debt Equity	INR 0.33
Tangible Book Value	INR 1.5B
Tangible Book Value Per Share	INR 53.06
WACC	10.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.15%
Dividend per share	INR 0
Last Dividend	INR 0.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	141.81%
1Y total return	65.82%
200-day SMA	74.25
3Y total return	208.87%
50-day SMA	73.95
50-day SMA vs 200-day SMA	50under200
5Y total return	182.15%
All Time High	144
All Time High Change	-39.04%
All Time High Date	2017-09-12
All Time Low	9.02
All Time Low Change	872.84%
All Time Low Date	2013-10-04
ATR	4.76
Beta	1.3
Beta1y	1.55
Beta2y	1.03
Ch YTD	29.65
High	90.85
High52	100
High52 Date	2025-11-06
High52ch	-12.25%
Low	87.6
Low52	49.01
Low52 Date	2025-06-05
Low52ch	79.05%
Ma50ch	18.66%
Price vs 200-day SMA	18.18%
RSI	65.07
RSI Monthly	59.86
RSI Weekly	62
Sharpe ratio	1.2x
Sortino ratio	1.87
Total Return	-4.15%
Tr YTD	29.65
Tr15y	362.24%
Tr1m	47.23%
Tr1w	-2.61%
Tr3m	30.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 3.7M
Operating Income Growth	-96.53
Operating Income Growth3 Y	-60.57
Operating Income Growth5 Y	-44.62
Operating margin	0.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	13,228,101%
Shares Insiders	39.03%
Shares Institutions	2.78%
Shares Out	28,454,303
Shares Qo Q	0%
Shares Yo Y	4.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	14,335.45x
Bv Per Share	53.06
Ch10y	141.1
Ch15y	360.8
Ch1m	47.23
Ch1w	-2.61
Ch1y	65.82
Ch3m	30.6
Ch3y	208.9
Ch5y	182.2
Ch6m	-10.01
Change	-1.87%
Change From Open	-1.87
Close	89.42
Days Gap	0
Depreciation Amortization	21,300,750
Dollar Volume	21,762
Earnings Date	2026-05-26
EBIT	INR 3.7M
EBITDA	INR 25M
EPS	INR 1.19
F Score	1
Fiscal Year End	March
Founded	1,990
Graham Number	37.74937
Graham Upside	-56.98
Income Tax	INR 23.2M
Is Primary Listing	1
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Last Split Date	2012-06-25
Last Split Type	Forward
Lynch Fair Value	INR 5.97
Lynch Upside	-93.2
Ma150	76.3
Ma150ch	15.01%
Ma20	84.68
Ma20ch	3.63%
Next Earnings Date	2026-05-26
Open	89.42
Position In Range	4.62
Price Date	2026-05-07
Price EBITDA	INR 105
Ptbv Ratio	1.76
Relative Volume	0.02x
Revenue	3,908,960,000x
Tax By Revenue	0.59x
Tax Rate	40.36%
Tr6m	-10.01%
Volume	248

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does BOM/524412 pay a dividend?

Capital-return profile for this ticker.

Performance

BOM/524412 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BOM/524412?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+39.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+4.2%

Negative means the company is buying back shares.

Technical

BOM/524412 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.1

Neutral momentum band

Price vs 200-day MA

+18.2%

50/200-day relationship not available

Beta (5Y)

1.30

More volatile than the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BOM/524412

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/524412 stock rating?

bom/524412 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/524412 analysis?

The full report lives at /stocks/bom/524412/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/524412?

The latest report frames bom/524412 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/524412 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.